Altered T cell repertoire usage in CD4 and CD8 subsets of multiple myeloma patients, a study of the Eastern Cooperative Oncology Group (E9487)

Neil Elliot Kay, Traci Leong, Robert A. Kyle, Phillip Greipp, Brian Van Ness, Nancy Bone, Martin M. Oken

Research output: Contribution to journalArticle

29 Citations (Scopus)

Abstract

Previous investigations have demonstrated that an expanding circulating T cell population is able to modulate the malignant clone in multiple myeloma. More recently, an expansion of T cell subsets exhibiting a restricted T cell repertoire has been detected in some MM patients. To further elucidate if a selected T cell expansion occurs in MM, we studied the T cell receptor (TCR) variable (V) region expression from a cohort of previously diagnosed and treated MM patients (N = 37). The latter was done by assessing the reactivity of a panel of monoclonal antibodies specific for different V region families (α or β) in combination with anti-CD4 or anti-CD8, for purified blood T cells from MM patients. TCR V region usage in MM patients was compared to blood T cells from age matched (N = 13) control individuals. The multivariate analysis of variance did not uncover a difference for distribution of TCR V region usage between the normal controls and the MM cohort. However, there were individual MM patients who had expanded T cell with specific TCR V region expression when compared to the control group. Several MM patients had multiple, expanded CD4 and/or CD8 subsets based on TCR V region expression. The majority of MM patients had expanded T cell subsets that constituted less than 10% of the total blood T cell pool. However, a few MM patients (N = 3) had larger percentages (range 34-84%) of these expanded T cell subsets within their blood T (CD3+) cells. The stage of disease and treatment status (currently on or off therapy) did not associate with the pattern of restricted T cell repertoire. Finally, a smaller cohort of newly diagnosed, untreated MM patients (N = 13) also demonstrated an expanded T cell repertoire. However, these patients had more CD4 than CD8 cell subsets involved in the altered V region expression in several Vβ families. Thus, these results add to the evidence that this malignant B cell disorder whether newly diagnosed or of longer duration, may be accompanied by an altered T cell repertoire characterized in part by expanded T cell clones.

Original languageEnglish (US)
Pages (from-to)127-133
Number of pages7
JournalLeukemia and Lymphoma
Volume33
Issue number1-2
StatePublished - 1999
Externally publishedYes

Fingerprint

Multiple Myeloma
T-Lymphocytes
T-Cell Antigen Receptor
T-Lymphocyte Subsets
Blood Cells
Clone Cells
Analysis of Variance
B-Lymphocytes
Multivariate Analysis
Monoclonal Antibodies
Control Groups

Keywords

  • Altered T-cell repertoire
  • CD4-lymphocytes
  • CD8 lymphocytes
  • Flow cytometry
  • Lymphocyte subsets
  • Multiple myeloma
  • Phenotype

ASJC Scopus subject areas

  • Hematology
  • Oncology
  • Cancer Research

Cite this

Altered T cell repertoire usage in CD4 and CD8 subsets of multiple myeloma patients, a study of the Eastern Cooperative Oncology Group (E9487). / Kay, Neil Elliot; Leong, Traci; Kyle, Robert A.; Greipp, Phillip; Van Ness, Brian; Bone, Nancy; Oken, Martin M.

In: Leukemia and Lymphoma, Vol. 33, No. 1-2, 1999, p. 127-133.

Research output: Contribution to journalArticle

Kay, Neil Elliot ; Leong, Traci ; Kyle, Robert A. ; Greipp, Phillip ; Van Ness, Brian ; Bone, Nancy ; Oken, Martin M. / Altered T cell repertoire usage in CD4 and CD8 subsets of multiple myeloma patients, a study of the Eastern Cooperative Oncology Group (E9487). In: Leukemia and Lymphoma. 1999 ; Vol. 33, No. 1-2. pp. 127-133.
@article{74552e8dbf504384b213ab01e84636be,
title = "Altered T cell repertoire usage in CD4 and CD8 subsets of multiple myeloma patients, a study of the Eastern Cooperative Oncology Group (E9487)",
abstract = "Previous investigations have demonstrated that an expanding circulating T cell population is able to modulate the malignant clone in multiple myeloma. More recently, an expansion of T cell subsets exhibiting a restricted T cell repertoire has been detected in some MM patients. To further elucidate if a selected T cell expansion occurs in MM, we studied the T cell receptor (TCR) variable (V) region expression from a cohort of previously diagnosed and treated MM patients (N = 37). The latter was done by assessing the reactivity of a panel of monoclonal antibodies specific for different V region families (α or β) in combination with anti-CD4 or anti-CD8, for purified blood T cells from MM patients. TCR V region usage in MM patients was compared to blood T cells from age matched (N = 13) control individuals. The multivariate analysis of variance did not uncover a difference for distribution of TCR V region usage between the normal controls and the MM cohort. However, there were individual MM patients who had expanded T cell with specific TCR V region expression when compared to the control group. Several MM patients had multiple, expanded CD4 and/or CD8 subsets based on TCR V region expression. The majority of MM patients had expanded T cell subsets that constituted less than 10{\%} of the total blood T cell pool. However, a few MM patients (N = 3) had larger percentages (range 34-84{\%}) of these expanded T cell subsets within their blood T (CD3+) cells. The stage of disease and treatment status (currently on or off therapy) did not associate with the pattern of restricted T cell repertoire. Finally, a smaller cohort of newly diagnosed, untreated MM patients (N = 13) also demonstrated an expanded T cell repertoire. However, these patients had more CD4 than CD8 cell subsets involved in the altered V region expression in several Vβ families. Thus, these results add to the evidence that this malignant B cell disorder whether newly diagnosed or of longer duration, may be accompanied by an altered T cell repertoire characterized in part by expanded T cell clones.",
keywords = "Altered T-cell repertoire, CD4-lymphocytes, CD8 lymphocytes, Flow cytometry, Lymphocyte subsets, Multiple myeloma, Phenotype",
author = "Kay, {Neil Elliot} and Traci Leong and Kyle, {Robert A.} and Phillip Greipp and {Van Ness}, Brian and Nancy Bone and Oken, {Martin M.}",
year = "1999",
language = "English (US)",
volume = "33",
pages = "127--133",
journal = "Leukemia and Lymphoma",
issn = "1042-8194",
publisher = "Informa Healthcare",
number = "1-2",

}

TY - JOUR

T1 - Altered T cell repertoire usage in CD4 and CD8 subsets of multiple myeloma patients, a study of the Eastern Cooperative Oncology Group (E9487)

AU - Kay, Neil Elliot

AU - Leong, Traci

AU - Kyle, Robert A.

AU - Greipp, Phillip

AU - Van Ness, Brian

AU - Bone, Nancy

AU - Oken, Martin M.

PY - 1999

Y1 - 1999

N2 - Previous investigations have demonstrated that an expanding circulating T cell population is able to modulate the malignant clone in multiple myeloma. More recently, an expansion of T cell subsets exhibiting a restricted T cell repertoire has been detected in some MM patients. To further elucidate if a selected T cell expansion occurs in MM, we studied the T cell receptor (TCR) variable (V) region expression from a cohort of previously diagnosed and treated MM patients (N = 37). The latter was done by assessing the reactivity of a panel of monoclonal antibodies specific for different V region families (α or β) in combination with anti-CD4 or anti-CD8, for purified blood T cells from MM patients. TCR V region usage in MM patients was compared to blood T cells from age matched (N = 13) control individuals. The multivariate analysis of variance did not uncover a difference for distribution of TCR V region usage between the normal controls and the MM cohort. However, there were individual MM patients who had expanded T cell with specific TCR V region expression when compared to the control group. Several MM patients had multiple, expanded CD4 and/or CD8 subsets based on TCR V region expression. The majority of MM patients had expanded T cell subsets that constituted less than 10% of the total blood T cell pool. However, a few MM patients (N = 3) had larger percentages (range 34-84%) of these expanded T cell subsets within their blood T (CD3+) cells. The stage of disease and treatment status (currently on or off therapy) did not associate with the pattern of restricted T cell repertoire. Finally, a smaller cohort of newly diagnosed, untreated MM patients (N = 13) also demonstrated an expanded T cell repertoire. However, these patients had more CD4 than CD8 cell subsets involved in the altered V region expression in several Vβ families. Thus, these results add to the evidence that this malignant B cell disorder whether newly diagnosed or of longer duration, may be accompanied by an altered T cell repertoire characterized in part by expanded T cell clones.

AB - Previous investigations have demonstrated that an expanding circulating T cell population is able to modulate the malignant clone in multiple myeloma. More recently, an expansion of T cell subsets exhibiting a restricted T cell repertoire has been detected in some MM patients. To further elucidate if a selected T cell expansion occurs in MM, we studied the T cell receptor (TCR) variable (V) region expression from a cohort of previously diagnosed and treated MM patients (N = 37). The latter was done by assessing the reactivity of a panel of monoclonal antibodies specific for different V region families (α or β) in combination with anti-CD4 or anti-CD8, for purified blood T cells from MM patients. TCR V region usage in MM patients was compared to blood T cells from age matched (N = 13) control individuals. The multivariate analysis of variance did not uncover a difference for distribution of TCR V region usage between the normal controls and the MM cohort. However, there were individual MM patients who had expanded T cell with specific TCR V region expression when compared to the control group. Several MM patients had multiple, expanded CD4 and/or CD8 subsets based on TCR V region expression. The majority of MM patients had expanded T cell subsets that constituted less than 10% of the total blood T cell pool. However, a few MM patients (N = 3) had larger percentages (range 34-84%) of these expanded T cell subsets within their blood T (CD3+) cells. The stage of disease and treatment status (currently on or off therapy) did not associate with the pattern of restricted T cell repertoire. Finally, a smaller cohort of newly diagnosed, untreated MM patients (N = 13) also demonstrated an expanded T cell repertoire. However, these patients had more CD4 than CD8 cell subsets involved in the altered V region expression in several Vβ families. Thus, these results add to the evidence that this malignant B cell disorder whether newly diagnosed or of longer duration, may be accompanied by an altered T cell repertoire characterized in part by expanded T cell clones.

KW - Altered T-cell repertoire

KW - CD4-lymphocytes

KW - CD8 lymphocytes

KW - Flow cytometry

KW - Lymphocyte subsets

KW - Multiple myeloma

KW - Phenotype

UR - http://www.scopus.com/inward/record.url?scp=0032970781&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032970781&partnerID=8YFLogxK

M3 - Article

C2 - 10194129

AN - SCOPUS:0032970781

VL - 33

SP - 127

EP - 133

JO - Leukemia and Lymphoma

JF - Leukemia and Lymphoma

SN - 1042-8194

IS - 1-2

ER -